Nomura on IKS Health
Nomura initiated Buy with a target of Rs. 2000, citing strong prospects in US healthcare outsourcing.
UBS on Britannia
UBS maintained Buy with a target of Rs. 6350, saying Q3 volume trends remain strong and margin expansion may resume.
CLSA on HAL
CLSA maintained Outperform with a TP of Rs. 5436 after the Tejas Mk1 incident, with no major financial impact expected.
Bernstein on Swiggy & Eternal
Bernstein said labour codes may reduce EBITDA by 25–70 bps; long-term profitability remains intact. Maintains Outperform.
Emkay on India E-Commerce
Emkay maintained Buy on Eternal (Rs. 415 TP) and Accumulate on Swiggy (Rs. 490 TP), noting most cost impact may be passed on.
UBS on Shaily Engineering
UBS initiated Buy with a target of Rs. 4000, citing injector-pen technology and strong GLP-1 opportunity. Forecasts 75 percent EPS CAGR in FY25-28.
Ambit on Auto NBFCs
Ambit expects asset quality to improve over 6–9 months and EPS CAGR of 20–28 percent over FY26-28 for Chola and Shriram Finance.
Elara on HAL
Elara reiterated Buy with a target of Rs. 5680; crash impact minimal but Mk1A export timelines may shift.
JP Morgan Sector View
JP Morgan prefers PSU banks, NBFCs and capital market plays; remains underweight IT.
Citi Sector & Market Outlook
Citi said BFSI margins have bottomed, telecom and hospitals remain long-term favourites, and a US-India trade deal could be a major catalyst reversing India’s underperformance.
Leave A Comment